Cinda Biotech (01801.HK) grants stock options and restricted shares

Gelonghui March 31丨Cinda Biologics (01801.HK) issued an announcement. On March 30, 2026, pursuant to the terms of the 2024 share plan, the company granted 1.9356 million share options to 66 grantees (including directors) and granted 10.2413 million restricted shares to 1,308 grantees, subject to acceptance by the grantees.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments